Comorbidity and Its Impact on Patients with COVID-19

The coronavirus disease may have an impact on the health of infected individuals depending on their pre-existing comorbidities. An overview of the association between comorbidities and disease aggravation in COVID-19 patients that might result in poor clinical outcomes or death, is provided here. Additionally, general medical issues are discussed, including the symptoms that individuals infected with SARS-CoV-2 may exhibit. Persons with COVID-19 who also have concomitant comorbidities like diabetes mellitus or hypertension are at a higher risk of experiencing a more severe course and progression of the illness. Additionally, older patients with comorbidities particularly those 65 years of age and older, had a higher rate of ICU admissions and COVID-19 disease mortality. A total of 355 hospitalized COVID-19 patients were identified from four dedicated COVID hospitals. Total death among the hospitalized COVID-19 patients was 8.7%, among them 83.8% was >65 years old and 80.6% had comorbidities. Comorbid patients typically have the worst prognosis, thus they should take every care to prevent contracting SARS CoV-2.

Authors

Publication Details

Journal
SAS Journal of Medicine
Published
2025-03-06
DOI
https://doi.org/10.36347/sasjm.2025.v11i03.003
Citations
3
Primary Topic
Chronic Disease Management Strategies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comorbidity and Its Impact on Patients with COVID-19

Tamanna Bahar, Muhammad Nazrul Islam, Goutam Kumar Acherjya, Keya Tarafder et al.
3 citations
SAS Journal of Medicine
Chronic Disease Management Strategies
article

Comorbidity and Its Impact on Patients with COVID-19

Tamanna Bahar, Muhammad Nazrul Islam, Goutam Kumar Acherjya, Keya Tarafder, Md. Ashraful Haque Chowdhury, Mohammad Ali, Mohammad Wasim, Salina Haque
article en
3 citations

Abstract

The coronavirus disease may have an impact on the health of infected individuals depending on their pre-existing comorbidities. An overview of the association between comorbidities and disease aggravation in COVID-19 patients that might result in poor clinical outcomes or death, is provided here. Additionally, general medical issues are discussed, including the symptoms that individuals infected with SARS-CoV-2 may exhibit. Persons with COVID-19 who also have concomitant comorbidities like diabetes mellitus or hypertension are at a higher risk of experiencing a more severe course and progression of the illness. Additionally, older patients with comorbidities particularly those 65 years of age and older, had a higher rate of ICU admissions and COVID-19 disease mortality. A total of 355 hospitalized COVID-19 patients were identified from four dedicated COVID hospitals. Total death among the hospitalized COVID-19 patients was 8.7%, among them 83.8% was >65 years old and 80.6% had comorbidities. Comorbid patients typically have the worst prognosis, thus they should take every care to prevent contracting SARS CoV-2.

SAS Journal of MedicineVol. 11(03)
Openalex Percentile: Top 94%
Chronic Disease Management Strategies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comorbidity and Its Impact on Patients with COVID-19 — Tamanna Bahar, Muhammad Nazrul Islam, et al. · SAS Journal of Medicine (2025) | TGRS Research Map | TGRS